Health-Related Quality of Life in Chronic HCV-Infected Patients Switching to Pegylated-Interferon-Free Regimens (ANRS CO20 CUPIC Cohort Study and SIRIUS Trial). [electronic resource]
Producer: 20180725Description: 605-614 p. digitalISSN:- 1178-1661
- Age Factors
- Aged
- Antiviral Agents -- administration & dosage
- Benzimidazoles -- administration & dosage
- Cohort Studies
- Comorbidity
- Double-Blind Method
- Female
- Fluorenes -- administration & dosage
- Health Status
- Hepatitis C, Chronic -- drug therapy
- Humans
- Male
- Mental Health
- Middle Aged
- Oligopeptides -- therapeutic use
- Patient Reported Outcome Measures
- Polyethylene Glycols
- Proline -- analogs & derivatives
- Quality of Life
- Severity of Illness Index
- Sex Factors
- Sofosbuvir
- Sustained Virologic Response
- Uridine Monophosphate -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.